My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.240 +0.060 (+2.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

Iovance Biotherapeutics to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 3, 2022

October 24, 2022

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Expert Ratings for Iovance Biotherapeutics ↗

August 05, 2022

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

Via Benzinga

7 Analysts Have This to Say About Iovance Biotherapeutics ↗

July 01, 2022

Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter:

Via Benzinga

4 Analysts Have This to Say About Iovance Biotherapeutics ↗

May 24, 2022

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

Via Benzinga

Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy

October 10, 2022

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

October 05, 2022

Oral Presentation of C-144-01 Trial Cohorts 2 and 4

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

5 Top Stocks Cathie Wood Is Selling This Week ↗

August 26, 2022

Cathie Wood and her flagship ETF ARKK received $54.2 million of inflows earlier this month. Here's what she's selling.

Via InvestorPlace

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 25, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Iovance Biotherapeutics: Q2 Earnings Insights ↗

August 04, 2022

Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022

July 27, 2022

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

40 Stocks Moving In Friday's Mid-Day Session ↗

June 03, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Via Benzinga

Insiders Buy Around $10M Of 3 Stocks ↗

June 03, 2022

Although the Dow Jones jumped more than 400 points on Thursday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 31, 2022

On Tuesday, 36 companies achieved new lows for the year.

Via Benzinga

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

Mid-Afternoon Market Update: Dow Gains 500 Points; Red Robin Gourmet Burgers Shares Spike Higher ↗

May 27, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 500 points on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 27, 2022

Gainers

Via Benzinga

Gas Price Predictions: How Much Will Gas Cost Over Memorial Day Weekend? ↗

May 27, 2022

Anyone planning to travel over the Memorial Day Weekend is going to want to check out the latest gas price predictions.

Via InvestorPlace

Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today? ↗

May 27, 2022

Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Higher; US Goods Trade Deficit Narrows In April ↗

May 27, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 27, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 27, 2022

We're starting the final day of trading for the week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

May 27, 2022

Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 26, 2022

Gainers

Via Benzinga

Iovance Biotherapeutics Just Flashed A Bullish Sign Despite Melanoma Drug Delay ↗

April 07, 2022

This biotech stock is mounting a two-day recovery and is well above its 50-day line.

Via Investor's Business Daily

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.